- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03817385
rTMS and Robotic Gait Training in Patients With Stroke
Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) and Robotic Gait Training on Lower-extremity Function and Gait in Patients With Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: PangTa Liu
- Phone Number: 7427 886-4-7238595
- Email: 105546@cch.org.tw
Study Locations
-
-
-
Changhua, Taiwan, 500
- Recruiting
- Changhua Christian Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- first-time onset of stroke
- reaching 20 years old and having clinical CT and MRI diagnosis of stroke
- hemiparesis with sitting ability after onset 3 months
Exclusion Criteria:
- Brunnstrom stage over grade V
- Combined other neurological diseases (epilepsy, polyneuropathy, Meniere's disease, vestibular neuritis, Parkinson's disease, dementia, spinocerebellar ataxia)
- lower extremity disease, included joint contracture, high muscle tone(MAS more than 3), L/E fracture, Joint replacement, long-term osteoarthritis pain
- unstable vital sign
- can't coordinate or Sign consent plan form
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: repetitive TMS (Transcranial Magnetic Stimulation)
rTMS and physical / occupational therapy
|
rTMS x 10 times
|
EXPERIMENTAL: robotic GT (Gait Training)
robotic gait training for 20 times and physical / occupational therapy
|
robotic gait training for 20 times
|
NO_INTERVENTION: traditional rehabilitation
patient only received traditional rehabilitation program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of walking speed
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
walk 6m to measure the time spent, patients can walk with foot orthosis and assistive devices
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of postural sway displacement
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure the postural sway displacement (mm)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of postural sway velocity
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure the postural sway velocity (mm/s)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of postural sway area
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
computerized dynography to measure the postural sway area (mm^2)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of step time
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure spatial gait parameter: step time (ms)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of stance time
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure spatial gait parameter: stance time (ms)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of swing time
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure spatial gait parameter: swing time (ms)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of single support time
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure spatial gait parameter: single support time (ms)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of double support time
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure spatial gait parameter: double support time (ms)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of step length
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure spatial gait parameter: step distance (mm)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of stance length
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Use computerized dynography to measure spatial gait parameter: stance distance (mm)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of amplitude of Muscle activity
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
use electromyography to measure the muscles activity in microvolts (uv) included quadriceps, hamstrings, tibialis anterior, gastrocnemius during subject walking in self selected speed in 6 meters.
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of Functional Independence Measure (FIM)
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
FIM™ is comprised of 18 items, grouped into 2 subscales - motor and cognition. The motor subscale includes: Eating Grooming Bathing Dressing, upper body Dressing, lower body Toileting Bladder management Bowel management Transfers - bed/chair/wheelchair Transfers - toilet Transfers - bath/shower Walk/wheelchair Stairs The cognition subscale includes: Comprehension Expression Social interaction Problem solving Memory Each item is scored on a 7 point ordinal scale, ranging from a score of 1 to a score of 7. The higher the score, the more independent the patient is in performing the task associated with that item. The total score for the FIM motor subscale will be a value between 13 and 91. The total score for the FIM cognition subscale will be a value between 5 and 35. The total score for the FIM instrument will be a value between 18 and 126. |
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of international Quality of Life Assessment Short Form -36 (SF-36)
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
including 8 health concepts: (1) physical functioning, (2) role limitations because of physical health problems; (3) bodily pain, (4) social functioning, (5) general mental health (psychological distress and psychological wellbeing), (6) role limitations because of emotional problems, (7) vitality (energy/fatigue), (8) general health perceptions. Scoring: answers to each question are scored which are then summed and transformed to a 0 - 100 scale. |
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of concentration of Serum albumin
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
The concentration of Serum albumin in the blood test. Albumin is the most important contributor to the maintenance of plasma colloid oncotic pressure; deficiency results in edema.because of physical health problems; (3) bodily pain, (4) social functioning, (5) general mental health (psychological distress and psychological wellbeing), (6) role limitations because of emotional problems, (7) vitality (energy/fatigue), (8) general health perceptions. Scoring: answers to each question are scored which are then summed and transformed to a 0 - 100 scale. |
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of concentration of Hemoglobin (Hb)
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
The concentration of Hb in the blood test.
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of concentration of Glucose
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
The concentration of Glucose in the blood test.
The Spot glucose measurement in epidermal interstitial fluid appears to be a promising alternative to capillary blood glucose estimation
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of concentration of Cholesterol
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
The concentration of Cholesterol in the blood test.
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of concentration of Triglyceride
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
The concentration of Triglyceride in the blood test.
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of Berg balance test (BBS)
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Including 14 items which are scored on a 5 points scale (0-4). The degree of success in achieving each task is given a score of zero (unable) to four (independent), and the final measure is the sum of all of the scores. The item scores are summed, minimum score =0, maximum score = 56 |
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of Fugl-Meyer Assessment (FMA)
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Items are scored on a 3-point ordinal scale (0 = cannot perform; 1 = performs partially; 2 = performs fully) Maximum Score = 226 points The 5 domains assessed include, Motor function (Upper extremity maximum score = 66; Lower extremity maximum score = 34), Sensory function (maximum score = 24), Balance (maximum score = 14), Joint range of motion (maximum score = 44), Joint pain (maximum score = 44)
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of Body Mass Index (BMI)
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
(body weight) kg/(height) m*(height)m
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of Mini-mental state examination (MMSE)
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The maximum score is 30. A score of 23 or lower is indicative of cognitive impairment. |
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of Modified Ashworth scale (MAS)
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
measures resistance during passive soft-tissue stretching, the score is ranged from 0-4 0: No increase in muscle tone
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Change of Muscle tone
Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
measure the muscle tone (kg/m) under muscle resting.
Target muscles are quadriceps, hamstrings, anterior tibialis, gastrocnemius.
|
baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ta-Sen Wei, Doctor, Changhua Christian Hospital
Publications and helpful links
General Publications
- Brunt D, Greenberg B, Wankadia S, Trimble MA, Shechtman O. The effect of foot placement on sit to stand in healthy young subjects and patients with hemiplegia. Arch Phys Med Rehabil. 2002 Jul;83(7):924-9. doi: 10.1053/apmr.2002.3324.
- Dettmann MA, Linder MT, Sepic SB. Relationships among walking performance, postural stability, and functional assessments of the hemiplegic patient. Am J Phys Med. 1987 Apr;66(2):77-90.
- Hidler J, Nichols D, Pelliccio M, Brady K. Advances in the understanding and treatment of stroke impairment using robotic devices. Top Stroke Rehabil. 2005 Spring;12(2):22-35. doi: 10.1310/RYT5-62N4-CTVX-8JTE.
- Kakuda W, Abo M, Watanabe S, Momosaki R, Hashimoto G, Nakayama Y, Kiyama A, Yoshida H. High-frequency rTMS applied over bilateral leg motor areas combined with mobility training for gait disturbance after stroke: a preliminary study. Brain Inj. 2013;27(9):1080-6. doi: 10.3109/02699052.2013.794973.
- Kim J, Park JH, Yim J. Effects of respiratory muscle and endurance training using an individualized training device on the pulmonary function and exercise capacity in stroke patients. Med Sci Monit. 2014 Dec 5;20:2543-9. doi: 10.12659/MSM.891112.
- Hornby TG, Campbell DD, Kahn JH, Demott T, Moore JL, Roth HR. Enhanced gait-related improvements after therapist- versus robotic-assisted locomotor training in subjects with chronic stroke: a randomized controlled study. Stroke. 2008 Jun;39(6):1786-92. doi: 10.1161/STROKEAHA.107.504779. Epub 2008 May 8. Erratum In: Stroke.2008 Aug;39(8): e143.
- Israel JF, Campbell DD, Kahn JH, Hornby TG. Metabolic costs and muscle activity patterns during robotic- and therapist-assisted treadmill walking in individuals with incomplete spinal cord injury. Phys Ther. 2006 Nov;86(11):1466-78. doi: 10.2522/ptj.20050266.
- Kim P, Warren S, Madill H, Hadley M. Quality of life of stroke survivors. Qual Life Res. 1999 Jun;8(4):293-301. doi: 10.1023/a:1008927431300.
- Macko RF, Ivey FM, Forrester LW, Hanley D, Sorkin JD, Katzel LI, Silver KH, Goldberg AP. Treadmill exercise rehabilitation improves ambulatory function and cardiovascular fitness in patients with chronic stroke: a randomized, controlled trial. Stroke. 2005 Oct;36(10):2206-11. doi: 10.1161/01.STR.0000181076.91805.89. Epub 2005 Sep 8.
- Ng SS, Hui-Chan CW. The timed up & go test: its reliability and association with lower-limb impairments and locomotor capacities in people with chronic stroke. Arch Phys Med Rehabil. 2005 Aug;86(8):1641-7. doi: 10.1016/j.apmr.2005.01.011.
- Nichols DS. Balance retraining after stroke using force platform biofeedback. Phys Ther. 1997 May;77(5):553-8. doi: 10.1093/ptj/77.5.553.
- Wang RY, Tseng HY, Liao KK, Wang CJ, Lai KL, Yang YR. rTMS combined with task-oriented training to improve symmetry of interhemispheric corticomotor excitability and gait performance after stroke: a randomized trial. Neurorehabil Neural Repair. 2012 Mar-Apr;26(3):222-30. doi: 10.1177/1545968311423265. Epub 2011 Oct 5.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCH-160102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on repetitive TMS
-
Children's Hospital Medical Center, CincinnatiNot yet recruitingAttention Deficit Hyperactivity Disorder
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Duke UniversityTerminated
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedOsteoarthritis, KneeUnited States
-
Emory UniversityNot yet recruiting
-
University of California, San FranciscoRecruiting
-
Sheba Medical CenterWeizmann Institute of ScienceCompletedParkinson's DiseaseIsrael
-
Suzhou Psychiatric HospitalCompleted
-
Sheba Medical CenterBrainswayUnknown